MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. (MBL) announced that it has entered into a collaboration agreement with the p53 Laboratory to establish the novel screening technology which accelerates the drug discovery targeting Protein-Protein Interactions (PPIs). MBL provides an innovative real-time PPI visualization technology called FluoppiTM to simultaneously visualize the cell permeability and intracellular activity of the PPI-targeted peptide therapeutic candidate developed by p53 Laboratory.